Comparative Nonclinical Assessments of the Proposed Biosimilar PF-05280014 and Trastuzumab (Herceptin).
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 451, doi. 10.1007/s40259-014-0103-4
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2014 AND VI 28 AND IP 5
Results: 6
1
2
Making Choices: Health Consumers, Regulation and the Global Stem Cell Therapy Market.
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 461, doi. 10.1007/s40259-014-0105-2
- By:
- Publication type:
- Article
3
Elosulfase Alfa: A Review of Its Use in Patients with Mucopolysaccharidosis Type IVA (Morquio A Syndrome).
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 465, doi. 10.1007/s40259-014-0108-z
- By:
- Publication type:
- Article
4
Tumor-Infiltrating Lymphocyte Therapy for Melanoma: Rationale and Issues for Further Clinical Development.
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 421, doi. 10.1007/s40259-014-0097-y
- By:
- Publication type:
- Article
5
Similar Names for Similar Biologics.
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 439, doi. 10.1007/s40259-014-0099-9
- By:
- Publication type:
- Article
6
Optimisation of Omalizumab Dosage in Patients with Severe Persistent Allergic Asthma Using recoveryELISA.
- Published in:
- BioDrugs, 2014, v. 28, n. 5, p. 445, doi. 10.1007/s40259-014-0101-6
- By:
- Publication type:
- Article